LifeStance Health (LFST) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.06
- EPS estimate
- $0.03
- EPS surprise
- +82.93%
- Revenue surprise
- +5.01%
- Revenue
- $435.4M
- Revenue estimate
- $414.6M
- Reported
- Aug 6, 2026
LifeStance Health reported Q2 2026 results on August 6, 2026. Earnings per share were $0.06, ahead of the $0.03 estimate by 82.93%. Revenue was $435.4 million, above the $414.6 million consensus. Compared with Q2 2025, when the company lost $0.01 per share, revenue rose about 26% from $345.3 million. Both EPS and revenue were the highest in the table.
The record shows a steady move from losses toward profit. LifeStance lost $0.61 per share in 2022, $0.51 in 2023 and $0.15 in 2024, then broke even at $0.00 in 2025. It has now earned a profit in each of the last three quarters. Revenue grew every year, from $859.6 million in 2022 to $1.42 billion in 2025, and each quarter in the table was higher than the same quarter a year earlier. LifeStance topped the EPS estimate 13 times over the last 20 quarters, including each of the last eight. Revenue beat estimates 17 times.
LifeStance reported Q3 between November 6 and November 8 in each of the past five years. That points to early November 2026 for the next report. It will show whether the recent profits continue and how revenue growth compares with recent quarters.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.03 | $0.06 | +82.93% | $435.4M | SEC |
| Q1 2026 | May 7, 2026 | $0.01 | $0.04 | +455.56% | $403.5M | SEC |
| Q4 2025 | Feb 25, 2026 | $0.00 | $0.01 | +194.12% | $382.2M | SEC |
| Q3 2025 | Nov 6, 2025 | −$0.01 | $0.00 | +100.00% | $363.8M | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.02 | −$0.01 | +58.85% | $345.3M | SEC |
| Q1 2025 | May 7, 2025 | −$0.03 | $0.00 | +100.00% | $333.0M | SEC |
| Q4 2024 | Feb 27, 2025 | −$0.04 | −$0.01 | +72.97% | $325.5M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.07 | −$0.02 | +70.50% | $312.7M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.07 | −$0.06 | +7.98% | $312.3M | SEC |
| Q1 2024 | May 9, 2024 | −$0.08 | −$0.06 | +24.43% | $300.4M | SEC |
| Q4 2023 | Feb 28, 2024 | −$0.09 | −$0.12 | −38.41% | $280.6M | SEC |
| Q3 2023 | Nov 8, 2023 | −$0.07 | −$0.17 | −148.90% | $262.9M | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.08 | −$0.13 | −71.28% | $259.6M | SEC |
| Q1 2023 | May 10, 2023 | −$0.09 | −$0.09 | +2.17% | $252.6M | SEC |
| Q4 2022 | Mar 8, 2023 | −$0.13 | −$0.13 | −1.56% | $229.4M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.14 | −$0.11 | +20.29% | $217.6M | SEC |
| Q2 2022 | Aug 9, 2022 | −$0.17 | −$0.19 | −15.08% | $209.5M | SEC |
| Q1 2022 | May 9, 2022 | −$0.19 | −$0.18 | +5.46% | $203.1M | SEC |
| Q4 2021 | Mar 10, 2022 | −$0.30 | −$0.31 | −2.11% | $190.1M | SEC |
| Q3 2021 | Nov 8, 2021 | −$0.03 | −$0.35 | −1078.45% | $173.8M | SEC |
Quarterly revenue
Frequently asked questions
When did LifeStance Health (LFST) last report earnings?
LifeStance Health last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did LFST beat earnings estimates?
Yes. LifeStance Health reported EPS of $0.06 for Q2 2026 against a $0.03 estimate — a 82.93% beat.
How much revenue did LFST report last quarter?
LifeStance Health reported $435.4M in revenue for Q2 2026, against a consensus estimate of $414.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.